Paul F. Cavanaugh

1.9k total citations
37 papers, 1.4k citations indexed

About

Paul F. Cavanaugh is a scholar working on Pharmacology, Molecular Biology and Periodontics. According to data from OpenAlex, Paul F. Cavanaugh has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 8 papers in Molecular Biology and 5 papers in Periodontics. Recurrent topics in Paul F. Cavanaugh's work include Inflammatory mediators and NSAID effects (15 papers), Drug-Induced Adverse Reactions (5 papers) and Oral microbiology and periodontitis research (4 papers). Paul F. Cavanaugh is often cited by papers focused on Inflammatory mediators and NSAID effects (15 papers), Drug-Induced Adverse Reactions (5 papers) and Oral microbiology and periodontitis research (4 papers). Paul F. Cavanaugh collaborates with scholars based in United States, Australia and Myanmar. Paul F. Cavanaugh's co-authors include Carl W. Porter, Raymond J. Bergeron, Janine T. Bryan, Eliav Barr, Terry Nolan, Xavier Castellsagué, Colin D. Marchant, Stan L. Block, Keith S. Reisinger and Katherine Giacoletti and has published in prestigious journals such as PEDIATRICS, Analytical Biochemistry and Clinical Cancer Research.

In The Last Decade

Paul F. Cavanaugh

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul F. Cavanaugh United States 21 393 312 254 220 165 37 1.4k
Eugene Eisenberg United States 25 586 1.5× 449 1.4× 101 0.4× 96 0.4× 317 1.9× 61 2.1k
Raffaele Grande Italy 23 143 0.4× 416 1.3× 752 3.0× 65 0.3× 137 0.8× 64 2.0k
P.J.A. HOLT United Kingdom 26 611 1.6× 577 1.8× 282 1.1× 83 0.4× 129 0.8× 86 2.2k
Sammy Al‐Benna Germany 22 302 0.8× 446 1.4× 397 1.6× 42 0.2× 274 1.7× 113 2.0k
Charles L. Berman United States 21 179 0.5× 474 1.5× 392 1.5× 88 0.4× 102 0.6× 47 2.8k
Henry Yeager United States 25 568 1.4× 389 1.2× 306 1.2× 203 0.9× 121 0.7× 57 2.8k
A. M. Sawyerr United Kingdom 21 621 1.6× 249 0.8× 817 3.2× 110 0.5× 128 0.8× 36 2.0k
Elisabeth Maurer Germany 22 383 1.0× 215 0.7× 242 1.0× 97 0.4× 359 2.2× 90 1.7k
Shuichi Abe Japan 25 367 0.9× 409 1.3× 257 1.0× 55 0.3× 126 0.8× 99 2.4k
Wen Ning China 29 465 1.2× 1.3k 4.2× 190 0.7× 88 0.4× 240 1.5× 97 2.8k

Countries citing papers authored by Paul F. Cavanaugh

Since Specialization
Citations

This map shows the geographic impact of Paul F. Cavanaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul F. Cavanaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul F. Cavanaugh more than expected).

Fields of papers citing papers by Paul F. Cavanaugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul F. Cavanaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul F. Cavanaugh. The network helps show where Paul F. Cavanaugh may publish in the future.

Co-authorship network of co-authors of Paul F. Cavanaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Paul F. Cavanaugh. A scholar is included among the top collaborators of Paul F. Cavanaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul F. Cavanaugh. Paul F. Cavanaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landau, Ruth, Paul F. Cavanaugh, & Mary DiGiorgi. (2023). Persistent opioid use after cesarean delivery in the United States of America: a systematic review. International Journal of Obstetric Anesthesia. 54. 103644–103644. 4 indexed citations
3.
Zeller, Robert S., et al.. (2012). Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions. Therapeutics and Clinical Risk Management. 8. 25–25. 32 indexed citations
5.
Schwartz, Jules I., Nancy Agrawal, Peggy H. Wong, et al.. (2009). Examination of the Effect of Increasing Doses of Etoricoxib on Oral Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 49(10). 1202–1209. 18 indexed citations
6.
Schwartz, Jules I., Aimée Dallob, Patrick Larson, et al.. (2008). Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects. The Journal of Clinical Pharmacology. 48(6). 745–754. 35 indexed citations
7.
Schwartz, Jules I., Nancy Agrawal, Uma Kher, et al.. (2007). Lack of Effect of Antacids on Single‐Dose Pharmacokinetics of Etoricoxib. The Journal of Clinical Pharmacology. 47(10). 1342–1346. 9 indexed citations
10.
Matsumoto, A K & Paul F. Cavanaugh. (2004). Etoricoxib. Drugs of today. 40(5). 395–395. 38 indexed citations
11.
Zhang, Fan, et al.. (2003). The overexpression of cyclo-oxygenase-2 in chronic periodontitis. The Journal of the American Dental Association. 134(7). 861–867. 39 indexed citations
12.
Klawansky, Sidney, Eugene Komaroff, Paul F. Cavanaugh, et al.. (2003). Relationship between age, renal function and bone mineral density in the US population. Osteoporosis International. 14(7). 570–576. 142 indexed citations
13.
Zimmermann, Nives, et al.. (1997). Development of a MIMIC-Based Polymerase Chain Reaction Technique for the Analysis of Prostaglandin Endoperoxide H Synthase Isoenzyme cDNAs. Analytical Biochemistry. 251(1). 110–113. 1 indexed citations
14.
Jeffcoat, Marjorie K., M. Sai Bhargava Reddy, I. Magnusson, et al.. (1996). Efficacy of quantitative digital subtraction radiography using radiographs exposed in a multicenter trial. Journal of Periodontal Research. 31(3). 157–160. 39 indexed citations
15.
Hausmann, E., et al.. (1996). Validation of Quantitative Digital Subtraction Radiography Using the Electronically Guided Alignment Device/Impression Technique. Journal of Periodontology. 67(9). 895–899. 32 indexed citations
16.
Cavanaugh, Paul F., et al.. (1995). Immunohistochemical localization of prostaglandin H synthase isoenzyme proteins in the gingival tissue of patients with periodontitis. Inflammopharmacology. 3(2). 109–119. 20 indexed citations
17.
Cavanaugh, Paul F.. (1995). The use of ketorolac tromethamine oral rinse for the treatment of periodontitis in adults. Inflammopharmacology. 3(4). 313–320. 3 indexed citations
18.
Cavanaugh, Paul F., et al.. (1990). A semi-automated neutral red based chemosensitivity assay for drug screening. Investigational New Drugs. 8(4). 347–354. 32 indexed citations
19.
Porter, Carl W., Paul F. Cavanaugh, Neal J. Stolowich, et al.. (1985). Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.. PubMed. 45(5). 2050–7. 107 indexed citations
20.
Cavanaugh, Paul F., et al.. (1982). Selectivity of antitemplates as inhibitors of deoxyribonucleic acid polymerases. Biochemical Pharmacology. 31(24). 4055–4060. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026